Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 12.51 billion as of August 15, 2025. Its market cap has decreased by -21.73% in one year.

Market Cap

12.51B

Enterprise Value

10.61B

Revenue

34.23M

Ranking

n/a

PE Ratio

n/a

Stock Price

102.00

Market Cap Chart

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 12.51B, an increase of 41.06%. That is a compound annual growth rate of 4.12%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	12.57B	-12.53%
Dec 31, 2024	14.37B	-31.28%
Dec 29, 2023	20.91B	-42.13%
Dec 30, 2022	36.13B	16.16%
Dec 30, 2021	31.10B	17.15%
Dec 31, 2020	26.55B	222.07%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	208.61B
PharmaEssentia	169.30B
Bora Pharmaceuticals Co., LTD.	94.94B
Lotus Pharmaceutical	53.91B
Oneness Biotech	32.23B
Polaris Group	27.47B
Lumosa Therapeutics	27.18B
Center Laboratories	26.42B

Market Cap Rankings